Gland Pharma

Gland PharmaGLAND.NS


$ 24.1409

Market Capitalization

$ 3.98 B

Shares Outstading

164.752 M


$ 0.46

Percentage Change

1.94 %


India 🇮🇳


Drug Manufacturers—General



National Stock Exchange of India



Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products un

PS Ratio of Gland Pharma ( GLAND.NS)

PS Ratio : 7.17999

Gland Pharma has PS Ratio of 7.17999 .The current price of Gland Pharma is $24.1409 (1.94 %).

The Price-to-Sales (P/S) ratio is a financial metric that compares a company's market capitalization to its total revenue. It provides insight into how the market values a company's sales performance, serving as an indicator of the company's revenue-generating capability. A lower P/S ratio may suggest a relatively undervalued stock, while a higher ratio may indicate a premium valuation.
PS Ratio of Gland Pharma from 2020 to 2024
Year on Year PS Ratio of Gland Pharma
PS Ratio
YearPS RatioChange %
Market Cap of Magnificent 7

Stock Ticker

Market Cap



Price(30 Days)


$ 3.352 T

$ 218.63


$ -6.38

United States🇺🇸

$ 3.211 T

$ 432.06


$ -12.79

United States🇺🇸

$ 2.903 T

$ 118.02


$ -4.57

United States🇺🇸

$ 2.159 T

$ 175.63


$ -7.97

United States🇺🇸

$ 1.905 T

$ 183.06


$ -3.35

United States🇺🇸

$ 1.808 T

$ 7.47005


$ -0.03

Saudi Arabia🇸🇦

$ 1.192 T

$ 469.96


$ -18.73

United States🇺🇸


MarketStreak weekly Newsletter

Get weekly Stock Market/Crypto News and Jobs updates directly to your inbox.

MarketStreak Research


Latest data-backed business trends, research insights, and industry analyses.

MarketStreak Inc.

Bangalore, India 🇮🇳

Disclaimer : The content on our website, including hyperlinked sites, associated applications, forums, blogs, and social media accounts, is for general information only and sourced from third-party providers. We offer no warranties regarding the content's accuracy or updatedness. Please note that our content should not be considered financial or legal advice. Always conduct thorough research and consult with a financial advisor before making any decisions. Trading is a high-risk activity that can lead to significant losses, so please seek professional guidance before making any trading decisions. Our content is not meant to be a solicitation or offer.